Blogs

Stay informed with the latest trends, updates, and expert insights in quality assurance, regulatory affairs, and compliance. Our blogs are designed to keep you ahead in the ever-evolving world of healthcare and pharmaceuticals.

Top GMP and Pharmacovigilance Audit Findings and How to Avoid Them

Top GMP and Pharmacovigilance Audit Findings and How to Avoid Them

MHRA Inspection Readiness: A Detailed January Checklist for UK Pharma Companies

MHRA Inspection Readiness: A Detailed January Checklist for UK Pharma Companies

GMP, GDP and GVP Audits: What Pharma Companies Should Plan at the Start of the Year

GMP, GDP and GVP Audits: What Pharma Companies Should Plan at the Start of the Year

Top 5 Regulatory Changes Impacting Pharma in 2026 (And How to Prepare)

Top 5 Regulatory Changes Impacting Pharma in 2026 (And How to Prepare)

The Cost of Non-Compliance: Why Investing in Quality Systems Pays Off in 2026

The Cost of Non-Compliance: Why Investing in Quality Systems Pays Off in 2026

Post-Market Surveillance Evolution: What Changed in PV Regulations for 2026

Post-Market Surveillance Evolution: What Changed in PV Regulations for 2026

AI-Driven GMP Audits: Transforming Pharma Compliance in 2026

AI-Driven GMP Audits: Transforming Pharma Compliance in 2026

Risk-Based Auditing: How to Spot Problems Before They Become Crises

Risk-Based Auditing: How to Spot Problems Before They Become Crises

GxP Inspection Trends for 2026: What Health Authorities Are Targeting Now

GxP Inspection Trends for 2026: What Health Authorities Are Targeting Now

5 Critical Mistakes Companies Make During PV Inspections (And How to Avoid Them in 2026)

5 Critical Mistakes Companies Make During PV Inspections (And How to Avoid Them in 2026)

Why Your Pharmacovigilance System Master File Could Fail Your Next Inspection

Why Your Pharmacovigilance System Master File Could Fail Your Next Inspection

The Hidden Costs of Poor ICSR Case Processing: Why Quality Matters More Than Speed

The Hidden Costs of Poor ICSR Case Processing: Why Quality Matters More Than Speed

Real World Evidence RWE in Regulatory Submissions: FDA and EMA Acceptance Criteria

Real World Evidence RWE in Regulatory Submissions: FDA and EMA Acceptance Criteria

How to Prepare for an MHRA Inspection: Expert Tips from Quality and Vigilance

How to Prepare for an MHRA Inspection: Expert Tips from Quality and Vigilance

Brexit Impact on UK Pharmaceutical Regulations: What Has Changed in 2025

Brexit Impact on UK Pharmaceutical Regulations: What Has Changed in 2025

Diversity & Inclusion in Drug Safety: Ensuring PV Systems Monitor All Patient Groups Equitably

Diversity & Inclusion in Drug Safety: Ensuring PV Systems Monitor All Patient Groups Equitably

Patient-Generated Safety Data: Wearables, Social Media & Mobile Reporting – What Auditors Need to Know

Patient-Generated Safety Data: Wearables, Social Media & Mobile Reporting – What Auditors Need to Know

Strengthening Pharmacovigilance in Low- and Middle-Income Countries (LMICs)

Strengthening Pharmacovigilance in Low- and Middle-Income Countries (LMICs)

Preparing for the Next Generation of Regulation: How Upcoming Guidelines Will Shape Pharmacovigilance Audits

Preparing for the Next Generation of Regulation: How Upcoming Guidelines Will Shape Pharmacovigilance Audits

Pharmacovigilance for Advanced Therapies: Auditing Safety in Cell, Gene and Tissue Products

Pharmacovigilance for Advanced Therapies: Auditing Safety in Cell, Gene and Tissue Products

Ethical Considerations in Patient-Centric Pharmacovigilance: Auditing Consent, Privacy and Data Use in Digital Health

Ethical Considerations in Patient-Centric Pharmacovigilance: Auditing Consent, Privacy and Data Use in Digital Health

Getting Inspection-Ready for 2026: How to Prepare Your Pharmaceutical Site Now

Getting Inspection-Ready for 2026: How to Prepare Your Pharmaceutical Site Now

Pharmacovigilance in Rare Diseases and Orphan Drugs: Ensuring Safety in Challenging Therapeutic Areas

Pharmacovigilance in Rare Diseases and Orphan Drugs: Ensuring Safety in Challenging Therapeutic Areas

Pharmacovigilance for Medical Devices and IVDs: Ensuring Safety and Compliance

Pharmacovigilance for Medical Devices and IVDs: Ensuring Safety and Compliance

What Makes a Good Pharmacovigilance System Master File (PSMF)

What Makes a Good Pharmacovigilance System Master File (PSMF)

Pharmacovigilance Outsourcing: Benefits, Risks, and Selection Tips

Pharmacovigilance Outsourcing: Benefits, Risks, and Selection Tips

The Economics of Pharmacovigilance: Cost vs. Patient Safety Benefits

The Economics of Pharmacovigilance: Cost vs. Patient Safety Benefits

Global Harmonisation of Pharmacovigilance Standards

Global Harmonisation of Pharmacovigilance Standards

Post-Marketing Surveillance: Why It Matters in Pharmacovigilance

Post-Marketing Surveillance: Why It Matters in Pharmacovigilance

Understanding Adverse Drug Reactions: The Core of Pharmacovigilance

Understanding Adverse Drug Reactions: The Core of Pharmacovigilance

How Real-World Evidence is Enhancing UK Pharmacovigilance Systems

How Real-World Evidence is Enhancing UK Pharmacovigilance Systems

Sustainability in Pharma Supply Chains: Aligning GDP with Environmental Responsibility

Sustainability in Pharma Supply Chains: Aligning GDP with Environmental Responsibility

The Future of Qualified Person for Pharmacovigilance (QPPV): Expanding Roles in a Digital Age

The Future of Qualified Person for Pharmacovigilance (QPPV): Expanding Roles in a Digital Age

Temperature Excursions in the Supply Chain: Best Practices for GDP Compliance

Temperature Excursions in the Supply Chain: Best Practices for GDP Compliance

Patient-Centric Pharmacovigilance: Leveraging Apps, Wearables, and Digital Health Tools for Safety Monitoring

Patient-Centric Pharmacovigilance: Leveraging Apps, Wearables, and Digital Health Tools for Safety Monitoring

Pharmacovigilance in the Era of Personalised Medicine and Gene Therapies

Pharmacovigilance in the Era of Personalised Medicine and Gene Therapies

AI and Machine Learning in Pharmacovigilance: How Technology is Transforming Drug Safety

AI and Machine Learning in Pharmacovigilance: How Technology is Transforming Drug Safety

The Role of Contract Storage Facilities in GxP Compliance and How Audits Help

The Role of Contract Storage Facilities in GxP Compliance and How Audits Help

Printed Packaging & Labelling Audits: Avoiding Regulatory Pitfalls in Artwork and Information Accuracy

Printed Packaging & Labelling Audits: Avoiding Regulatory Pitfalls in Artwork and Information Accuracy

Auditing Distributors and Warehouses: Safeguarding Product Integrity Across the Supply Chain

Auditing Distributors and Warehouses: Safeguarding Product Integrity Across the Supply Chain

Remote and Hybrid Audits: The Future of Supplier Qualification in Pharma

Remote and Hybrid Audits: The Future of Supplier Qualification in Pharma

The Role of Contract Storage Facilities in GxP Compliance and How Audits Help

The Role of Contract Storage Facilities in GxP Compliance and How Audits Help

Why Vendor Audits are the Cornerstone of Pharmaceutical Supply Chain Compliance

Why Vendor Audits are the Cornerstone of Pharmaceutical Supply Chain Compliance

Third-Party Audits: Why They’re Essential for Supply Chain Confidence

Third-Party Audits: Why They’re Essential for Supply Chain Confidence

Secondary Packaging Facilities: Why They’re Not Immune to Regulatory Scrutiny

Secondary Packaging Facilities: Why They’re Not Immune to Regulatory Scrutiny

Medical Device Manufacturer Audits: Navigating ISO 13485 and MDR Requirements

Medical Device Manufacturer Audits: Navigating ISO 13485 and MDR Requirements

Why Contract Manufacturing Organisations (CMOs) Must Prepare for Unannounced Regulatory Inspections

Why Contract Manufacturing Organisations (CMOs) Must Prepare for Unannounced Regulatory Inspections

The Importance of Pharmacovigilance System Master File (PSMF) and QPPV Oversight

The Importance of Pharmacovigilance System Master File (PSMF) and QPPV Oversight

Corrective and Preventive Action (CAPA) & Post‑Inspection Follow‑Up: Ensuring Continuous Compliance

Corrective and Preventive Action (CAPA) & Post‑Inspection Follow‑Up: Ensuring Continuous Compliance

Training and Educating Staff: Strengthening Your Team for PV Inspections

Training and Educating Staff: Strengthening Your Team for PV Inspections

The Role of a Qualified Person for Pharmacovigilance (QPPV): Ensuring 24/7 Safety Oversight and Regulatory Compliance

The Role of a Qualified Person for Pharmacovigilance (QPPV): Ensuring 24/7 Safety Oversight and Regulatory Compliance

Newsletter Signup

Subscribe to our newsletter for the latest insights